GlassScriptPhysician profile
Hilaree B Milliron
NPI 1447412416
$3,394.05
in general payments reported to CMS, 2019-2025
30 companies · $371 in 2025
The $371 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $878 · 2020: $161 · 2021: $112 · 2022: $289 · 2023: $811 · 2024: $772 · 2025: $371.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,937 · Education: $18.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,936.75 |
| Education | $18.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $501.33 | 2023-2025 | Infinity Adaptis, Augment Injectable, Easyfuse |
| Biotissue Holdings INC. | $427.31 | 2021-2024 | |
| Smith+Nephew, INC. | $284.67 | 2019-2025 | Grafix Pl, Stravix Pl, Pico 14 |
| Amgen INC. | $282.49 | 2024-2025 | Krystexxa |
| Wright Medical Technology, INC. | $238.59 | 2019 | |
| Trilliant Surgical LLC. | $206.62 | 2019 | |
| Arthrex, INC. | $197.66 | 2023 | |
| Orthofix Medical, INC. | $164.99 | 2019-2023 | Physio-Stim, Spinal-Stim |
| Acera Surgical, INC. | $130.26 | 2023 | Restrata Wound Matrix |
| Solventum Corporation | $128.66 | 2025 | V.A.C.Instill, Abthera, V.A.C. Dermatac |
| Horizon Therapeutics Plc | $121.91 | 2019-2022 | |
| Medical Device Business Services, INC. | $101.18 | 2019 | |
| Amniox Medical, INC. | $76.28 | 2019-2020 | |
| Integra Lifesciences Corporation | $75.93 | 2024 | Tcc-Ez |
| Reel Surgical, INC. | $53.08 | 2023 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Melinta Therapeutics, LLC | $44.64 | 2019 | |
| Next Science LLC | $43.96 | 2023 | Xperience, Blastx, Surgx |
| Abbvie INC. | $41.48 | 2023 | |
| Organogenesis INC. | $38.58 | 2020-2023 | Puraply |
| Paratek Pharmaceuticals, INC. | $34.19 | 2024 | Nuzyra |
| Kci USA, INC. | $29.54 | 2019 | |
| Kerecis Limited | $26.03 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Curonix LLC | $22.37 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Nevro Corp. | $19.13 | 2024 | Senza |
| Pfizer INC. | $18.87 | 2019 | |
| Mimedx Group, INC. | $18.82 | 2025 | |
| Sandoz INC. | $18.48 | 2019 | |
| Abbott Laboratories | $17.54 | 2025 | Eterna |
| Ermi LLC | $16.46 | 2019 | |
| Celularity INC. | $13.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hilaree Milliron listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.